Isg15 controls p53 stability and functions

Cell Cycle

Volumn 13, Issue 14, 2014, Pages 2199-2209

  Huang, Yi Fu ^a   Wee, Sheena ^a   Gunaratne, Jayantha ^a   Lane, David P ^b   Bulavin, Dmitry V ^a,c  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c UNIVERSITY OF NICE SOPHIA ANTIPOLIS   (France)

Author keywords

Apoptosis; Isg15; P53; Protein degradation misfolded protein

Indexed keywords

INTERFERON STIMULATED GENE 15 PROTEIN; PROTEIN MDM2; PROTEIN P53; UBIQUITIN; UNCLASSIFIED DRUG; CYTOKINE; G1P2 PROTEIN, MOUSE; ISG15 PROTEIN, HUMAN; PROTEASOME; TP53 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; DNA DAMAGE; EMBRYO; GENE DELETION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN TARGETING; REGULATORY MECHANISM; UBIQUITINATION; ANIMAL; DEFICIENCY; GENETIC TRANSFECTION; GENETICS; HCT116 CELL LINE; HEK293 CELL LINE; HUMAN; KNOCKOUT MOUSE; MCF 7 CELL LINE; METABOLISM; RNA INTERFERENCE;

ANIMALS; CYTOKINES; HCT116 CELLS; HEK293 CELLS; HUMANS; MCF-7 CELLS; MICE, KNOCKOUT; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STABILITY; PROTEOLYSIS; RNA INTERFERENCE; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION; UBIQUITINS;

EID: 84904473529     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.29209     Document Type: Article

References (52)

1. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004; 429:86-92; PMID:15103385; http://dx.doi.org/10.1038/ nature02514
2. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387:296-9; PMID:9153395; http://dx.doi.org/10.1038/387296a0
3. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387:299-303; PMID:9153396; http://dx.doi.org/10.1038/387299a0
4. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 2003; 112:779-91; PMID:12654245; http://dx.doi.org/10. 1016/S0092-8674(03)00193-4
5. Asher G, Lotem J, Kama R, Sachs L, Shaul Y. NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci U S A 2002; 99:3099-104; PMID:11867746; http://dx.doi.org/10.1073/pnas.052706799
6. Moscovitz O, Tsvetkov P, Hazan N, Michaelevski I, Keisar H, Ben-Nissan G, Shaul Y, Sharon M. A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1. Mol Cell 2012; 47:76-86; PMID:22793692
7. Tsvetkov P, Reuven N, Shaul Y. Ubiquitinin-dependent p53 proteasomal degradation. Cell Death Differ 2010; 17:103-8; PMID:19557012; http://dx.doi.org/10.1038/cdd.2009.67
8. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998; 392:405-8; PMID:9537326; http://dx.doi.org/10.1038/32925
9. Maheswaran S, Englert C, Bennett P, Heinrich G, Haber DA. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev 1995; 9:2143-56; PMID:7657166; http://dx.doi.org/10.1101/gad.9.17.2143
10. Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation. Oncogene 2001; 20:910-20; PMID:11314026; http://dx.doi.org/10.1038/sj.onc. 1204171
11. Durfee LA, Lyon N, Seo K, Huibregtse JM. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell 2010; 38:722-32; PMID:20542004; http://dx.doi.org/ 10.1016/j.molcel.2010.05.002
12. Korant BD, Blomstrom DC, Jonak GJ, Knight E Jr. Interferon-induced proteins. Purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. J Biol Chem 1984; 259:14835-9; PMID:6501319
13. Kim MJ, Latham AG, Krug RM. Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc Natl Acad Sci U S A 2002; 99:10096-101; PMID:12114540; http://dx.doi.org/10.1073/pnas.152327499
14. Loeb KR, Haas AL. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem 1992; 267:7806-13; PMID:1373138
15. Malakhova O, Malakhov M, Hetherington C, Zhang DE. Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3. J Biol Chem 2002; 277:14703-11; PMID:11854279; http://dx.doi.org/10.1074/jbc.M111527200
16. Yang P, Yu Z, Gandahi JA, Bian X, Wu L, Liu Y, Zhang L, Zhang Q, Chen Q. The identification of c-Kit-positive cells in the intestine of chicken. Poult Sci 2012; 91:2264-9; PMID:22912461; http://dx.doi.org/10.3382/ps.2011-02076
17. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389:300-5; PMID:9305847; http://dx.doi.org/10.1038/38525
18. Liu M, Hummer BT, Li X, Hassel BA. Camptothecin induces the ubiquitin-like protein, ISG15, and enhances ISG15 conjugation in response to interferon. J Interferon Cytokine Res 2004; 24:647-54; PMID:15684817; http://dx.doi.org/10.1089/jir.2004.24.647
19. Kim KI, Giannakopoulos NV, Virgin HW, Zhang DE. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Mol Cell Biol 2004; 24:9592-600; PMID:15485925; http://dx.doi.org/10.1128/MCB.24.21.9592- 9600.2004
20. Wong JJ, Pung YF, Sze NS, Chin KC. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci U S A 2006; 103:10735-40; PMID:16815975; http://dx.doi.org/ 10.1073/pnas.0600397103
21. Zhao C, Beaudenon SL, Kelley ML, Waddell MB, Yuan W, Schulman BA, Huibregtse JM, Krug RM. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc Natl Acad Sci U S A 2004; 101:7578-82; PMID:15131269; http://dx.doi.org/10.1073/pnas.0402528101
22. Zou W, Zhang DE. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J Biol Chem 2006; 281:3989-94; PMID:16352599; http://dx.doi.org/10.1074/jbc.M510787200
23. Giannakopoulos NV, Luo JK, Papov V, Zou W, Lenschow DJ, Jacobs BS, Borden EC, Li J, Virgin HW, Zhang DE. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 2005; 336:496-506; PMID:16139798; http://dx.doi.org/10.1016/j.bbrc.2005.08.132
24. Malakhov MP, Kim KI, Malakhova OA, Jacobs BS, Borden EC, Zhang DE. High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J Biol Chem 2003; 278:16608-13; PMID:12582176; http://dx.doi.org/10.1074/jbc.M208435200
25. Takeuchi T, Kobayashi T, Tamura S, Yokosawa H. Negative regulation of protein phosphatase 2Cbeta by ISG15 conjugation. FEBS Lett 2006; 580:4521-6; PMID:16872604; http://dx.doi.org/10.1016/j.febslet.2006.07.032
26. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 2005; 102:10200-5; PMID:16009940; http://dx.doi.org/10.1073/pnas.0504754102
27. Desai SD, Haas AL, Wood LM, Tsai YC, Pestka S, Rubin EH, Saleem A, Nur-E-Kamal A, Liu LF. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res 2006; 66:921-8; PMID:16424026; http://dx.doi.org/10.1158/0008-5472.CAN-05-1123
28. Dastur A, Beaudenon S, Kelley M, Krug RM, Huibregtse JM. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem 2006; 281:4334-8; PMID:16407192; http://dx.doi.org/10.1074/ jbc.M512830200
29. Okumura F, Zou W, Zhang DE. ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP. Genes Dev 2007; 21:255-60; PMID:17289916; http://dx.doi.org/10.1101/gad.1521607
30. Malakhov MP, Malakhova OA, Kim KI, Ritchie KJ, Zhang DE. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem 2002; 277:9976-81; PMID:11788588; http://dx.doi.org/10.1074/jbc.M109078200
31. Bade VN, Nickels J, Keusekotten K, Praefcke GJ. Covalent protein modification with ISG15 via a conserved cysteine in the hinge region. PLoS One 2012; 7:e38294; PMID:22693631; http://dx.doi.org/10.1371/journal.pone.0038294
32. David Y, Ternette N, Edelmann MJ, Ziv T, Gayer B, Sertchook R, Dadon Y, Kessler BM, Navon A. E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes. J Biol Chem 2011; 286:44104-15; PMID:21965653; http://dx.doi.org/10.1074/jbc.M111.234559
33. Lee JT, Gu W. The multiple levels of regulation by p53 ubiquitination. Cell Death Differ 2010; 17:86-92; PMID:19543236; http://dx.doi.org/10.1038/cdd. 2009.77
34. Milner J, Cook A, Sheldon M. A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40. Oncogene 1987; 1:453-5; PMID:3330789
35. Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990; 9:1595-602; PMID:1691710
36. Meletis K, Wirta V, Hede SM, Nistér M, Lundeberg J, Frisén J. p53 suppresses the self-renewal of adult neural stem cells. Development 2006; 133:363-9; PMID:16368933; http://dx.doi.org/10.1242/dev.02208
37. Zhu YH, Zhang CW, Lu L, Demidov ON, Sun L, Yang L, Bulavin DV, Xiao ZC. Wip1 regulates the generation of new neural cells in the adult olfactory bulb through p53-dependent cell cycle control. Stem Cells 2009; 27:1433-42; PMID:19489034; http://dx.doi.org/10.1002/stem.65
38. Trinidad AG, Muller PA, Cuellar J, Klejnot M, Nobis M, Valpuesta JM, Vousden KH. Interaction of p53 with the CCT complex promotes protein folding and wild-type p53 activity. Mol Cell 2013; 50:805-17; PMID:23747015; http://dx.doi.org/10.1016/j.molcel.2013.05.002
39. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362:849-52; PMID:8479523; http://dx.doi.org/10.1038/362849a0
40. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67:425-79; PMID:9759494; http://dx.doi.org/10.1146/annurev.biochem.67.1.425
41. Glickman MH, Ciechanover A. The ubiquitinproteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82:373-428; PMID:11917093
42. Baugh JM, Viktorova EG, Pilipenko EV. Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination. J Mol Biol 2009; 386:814-27; PMID:19162040; http://dx.doi.org/10.1016/j.jmb.2008.12. 081
43. Jeon YJ, Choi JS, Lee JY, Yu KR, Kim SM, Ka SH, Oh KH, Kim KI, Zhang DE, Bang OS, et al. ISG15 modification of filamin B negatively regulates the type I interferon-induced JNK signalling pathway. EMBO Rep 2009; 10:374-80; PMID:19270716; http://dx.doi.org/10.1038/embor.2009.23
44. Pitha-Rowe I, Hassel BA, Dmitrovsky E. Involvement of UBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia. J Biol Chem 2004; 279:18178-87; PMID:14976209; http://dx.doi.org/10. 1074/jbc.M309259200
45. Guerra S, Cáceres A, Knobeloch KP, Horak I, Esteban M. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog 2008; 4:e1000096; PMID:18604270; http://dx.doi.org/10.1371/journal.ppat.1000096
46. Loo YM, Owen DM, Li K, Erickson AK, Johnson CL, Fish PM, Carney DS, Wang T, Ishida H, Yoneyama M, et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A 2006; 103:6001-6; PMID:16585524; http://dx.doi.org/10.1073/pnas.0601523103
47. Nicholl MJ, Robinson LH, Preston CM. Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. J Gen Virol 2000; 81:2215-8; PMID:10950979
48. Osiak A, Utermöhlen O, Niendorf S, Horak I, Knobeloch KP. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 2005; 25:6338-45; PMID:16024773; http://dx.doi.org/10.1128/MCB.25.15.6338-6345.2005
49. Christophorou MA, Ringshausen I, Finch AJ, Swigart LB, Evan GI. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 2006; 443:214-7; PMID:16957739; http://dx.doi.org/10.1038/ nature05077
50. Jiang D, Brady CA, Johnson TM, Lee EY, Park EJ, Scott MP, Attardi LD. Full p53 transcriptional activation potential is dispensable for tumor suppression in diverse lineages. Proc Natl Acad Sci U S A 2011; 108:17123-8; PMID:21969549; http://dx.doi.org/10.1073/pnas.1111245108
51. Rappsilber J, Mann M, Ishihama Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc 2007; 2:1896-906; PMID:17703201; http://dx.doi.org/10. 1038/nprot.2007.261
52. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 2011; 10:1794-805; PMID:21254760; http://dx.doi.org/10.1021/ pr101065j